These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29274582)

  • 1. Bioactivity evaluation of natural product α-mangostin as a novel xanthone-based lysine-specific demethylase 1 inhibitor to against tumor metastasis.
    Han C; Li Z; Hou J; Wang Z; Xu D; Xue G; Kong L
    Bioorg Chem; 2018 Feb; 76():415-419. PubMed ID: 29274582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target separation and antitumor metastasis activity of sesquiterpene-based lysine-specific demethylase 1 inhibitors from zedoary turmeric oil.
    Ren C; Lin Y; Liu X; Yan D; Xu X; Zhu D; Kong L; Han C
    Bioorg Chem; 2021 Mar; 108():104666. PubMed ID: 33550070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation.
    Duan YC; Guan YY; Zhai XY; Ding LN; Qin WP; Shen DD; Liu XQ; Sun XD; Zheng YC; Liu HM
    Eur J Med Chem; 2017 Jan; 126():246-258. PubMed ID: 27888721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of curcumin analogues as novel LSD1 inhibitors.
    Wang J; Zhang X; Yan J; Li W; Jiang Q; Wang X; Zhao D; Cheng M
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126683. PubMed ID: 31627991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening.
    Sun XD; Zheng YC; Ma CY; Yang J; Gao QB; Yan Y; Wang ZZ; Li W; Zhao W; Liu HM; Ding L
    J Biomol Struct Dyn; 2019 Oct; 37(16):4200-4214. PubMed ID: 30366512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of selective and reversible LSD1 inhibitors with anti-metastasis activity by high-throughput docking.
    Li L; Li R; Wang Y
    Bioorg Med Chem Lett; 2019 Feb; 29(4):544-548. PubMed ID: 30611617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavone-based natural product agents as new lysine-specific demethylase 1 inhibitors exhibiting cytotoxicity against breast cancer cells in vitro.
    Xu X; Peng W; Liu C; Li S; Lei J; Wang Z; Kong L; Han C
    Bioorg Med Chem; 2019 Jan; 27(2):370-374. PubMed ID: 30552007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors.
    Zheng YC; Ma J; Wang Z; Li J; Jiang B; Zhou W; Shi X; Wang X; Zhao W; Liu HM
    Med Res Rev; 2015 Sep; 35(5):1032-71. PubMed ID: 25990136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking.
    Zhou C; Kang D; Xu Y; Zhang L; Zha X
    Chem Biol Drug Des; 2015 Jun; 85(6):659-71. PubMed ID: 25346381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diverse bioactivity of α-mangostin and its therapeutic implications.
    Chavan T; Muth A
    Future Med Chem; 2021 Oct; 13(19):1679-1694. PubMed ID: 34410182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raloxifene, identified as a novel LSD1 inhibitor, suppresses the migration of renal cell carcinoma.
    Ma Y; Zheng Y; Ji Y; Wang X; Ye B
    Future Med Chem; 2021 Mar; 13(6):533-542. PubMed ID: 33527838
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of xanthone derivatives based on α-mangostin and their biological evaluation for anti-cancer agents.
    Fei X; Jo M; Lee B; Han SB; Lee K; Jung JK; Seo SY; Kwak YS
    Bioorg Med Chem Lett; 2014 May; 24(9):2062-5. PubMed ID: 24717154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021.
    Song Y; Zhang H; Yang X; Shi Y; Yu B
    Eur J Med Chem; 2022 Jan; 228():114042. PubMed ID: 34915312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPE-1, an orally active pyrimidine derivative, inhibits growth and mobility of human esophageal cancers by targeting LSD1.
    Wang B; Zhao B; Pang LP; Zhao YD; Guo Q; Wang JW; Zheng YC; Zhang XH; Liu Y; Liu GY; Guo WG; Wang C; Li ZH; Mao XJ; Yu B; Ma LY; Liu HM
    Pharmacol Res; 2017 Aug; 122():66-77. PubMed ID: 28571892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation.
    Sun K; Peng JD; Suo FZ; Zhang T; Fu YD; Zheng YC; Liu HM
    Bioorg Med Chem Lett; 2017 Nov; 27(22):5036-5039. PubMed ID: 29037950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.
    Duan YC; Ma YC; Qin WP; Ding LN; Zheng YC; Zhu YL; Zhai XY; Yang J; Ma CY; Guan YY
    Eur J Med Chem; 2017 Nov; 140():392-402. PubMed ID: 28987602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precise separation of lysine-specific demethylase 1 inhibitors from Corydalis yanhusuo using multi-mode counter-current chromatography guided by virtual screening.
    Lin Y; Luo J; Li L; Liu X; Wang W; Zhu L; Han C; Kong L
    J Chromatogr A; 2020 Aug; 1625():461294. PubMed ID: 32709337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin, a natural LSD1 inhibitor.
    Zheng YC; Shen DD; Ren M; Liu XQ; Wang ZR; Liu Y; Zhang QN; Zhao LJ; Zhao LJ; Ma JL; Yu B; Liu HM
    Bioorg Chem; 2016 Dec; 69():129-131. PubMed ID: 27814566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the binding mode of a novel LSD1 inhibitor by molecular docking and molecular dynamics simulations.
    Zhang X; Li M; Wang Y; Zhao Y
    J Recept Signal Transduct Res; 2015; 35(5):363-9. PubMed ID: 26364657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of LSD1 activity blocks REST-dependent medulloblastoma cell migration.
    Callegari K; Maegawa S; Bravo-Alegria J; Gopalakrishnan V
    Cell Commun Signal; 2018 Sep; 16(1):60. PubMed ID: 30227871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.